Amgen Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
167 result(s) found, displaying 61 to 70
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REPATHA evolocumab (rch) 420 mg/3.5 mL injection solution automated mini-doser AMD.
-
Prescription medicine decision summaryTGA Decision: Lumakras (sotorasib) is approved to treat adult patients with non-small cell lung cancer (NSCLC).
-
Prescription medicine registrationActive ingredients: sotorasib.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MVASI bevacizumab 100 mg/4 mL injection concentrated vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MVASI bevacizumab 400 mg/16 mL injection concentrated vial.
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd